rs762556795

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6

The NM_024422.6(DSC2):​c.4G>A​(p.Glu2Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000728 in 1,524,154 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000072 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000073 ( 0 hom. )

Consequence

DSC2
NM_024422.6 missense

Scores

5
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:6B:2

Conservation

PhyloP100: 3.94

Publications

1 publications found
Variant links:
Genes affected
DSC2 (HGNC:3036): (desmocollin 2) This gene encodes a member of the desmocollin protein subfamily. Desmocollins, along with desmogleins, are cadherin-like transmembrane glycoproteins that are major components of the desmosome. Desmosomes are cell-cell junctions that help resist shearing forces and are found in high concentrations in cells subject to mechanical stress. This gene is found in a cluster with other desmocollin family members on chromosome 18. Mutations in this gene are associated with arrhythmogenic right ventricular dysplasia-11, and reduced protein expression has been described in several types of cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2015]
DSCAS (HGNC:51116): (DSC1/DSC2 antisense RNA)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.09751704).
BP6
Variant 18-31101968-C-T is Benign according to our data. Variant chr18-31101968-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 199776.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DSC2NM_024422.6 linkc.4G>A p.Glu2Lys missense_variant Exon 1 of 16 ENST00000280904.11 NP_077740.1 Q02487-1
DSC2NM_004949.5 linkc.4G>A p.Glu2Lys missense_variant Exon 1 of 17 NP_004940.1 Q02487-2
DSCASNR_110785.1 linkn.136+245C>T intron_variant Intron 1 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DSC2ENST00000280904.11 linkc.4G>A p.Glu2Lys missense_variant Exon 1 of 16 1 NM_024422.6 ENSP00000280904.6 Q02487-1

Frequencies

GnomAD3 genomes
AF:
0.0000724
AC:
11
AN:
152036
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000119
AC:
14
AN:
118124
AF XY:
0.000169
show subpopulations
Gnomad AFR exome
AF:
0.000245
Gnomad AMR exome
AF:
0.0000441
Gnomad ASJ exome
AF:
0.000259
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000228
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000729
AC:
100
AN:
1372118
Hom.:
0
Cov.:
32
AF XY:
0.0000798
AC XY:
54
AN XY:
676542
show subpopulations
African (AFR)
AF:
0.0000334
AC:
1
AN:
29926
American (AMR)
AF:
0.0000287
AC:
1
AN:
34814
Ashkenazi Jewish (ASJ)
AF:
0.000121
AC:
3
AN:
24800
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34648
South Asian (SAS)
AF:
0.00
AC:
0
AN:
77722
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
34360
Middle Eastern (MID)
AF:
0.000203
AC:
1
AN:
4930
European-Non Finnish (NFE)
AF:
0.0000810
AC:
87
AN:
1073594
Other (OTH)
AF:
0.000122
AC:
7
AN:
57324
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000724
AC:
11
AN:
152036
Hom.:
0
Cov.:
32
AF XY:
0.0000943
AC XY:
7
AN XY:
74246
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41412
American (AMR)
AF:
0.0000655
AC:
1
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5114
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00318
AC:
1
AN:
314
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68008
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000304
Hom.:
0
Bravo
AF:
0.0000340
ExAC
AF:
0.000208
AC:
4

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:6Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Arrhythmogenic right ventricular dysplasia 11 Uncertain:3
Dec 12, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 2 of the DSC2 protein (p.Glu2Lys). This variant is present in population databases (rs762556795, gnomAD 0.03%). This missense change has been observed in individual(s) with arrhythmogenic right ventricular cardiomyopathy (PMID: 20864495). ClinVar contains an entry for this variant (Variation ID: 199776). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Nov 10, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Oct 05, 2018
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Glu2Lys variant (rs762556795) was reported in one patient with palpitation at 15 years age of onset without a family history (Christensen 2010). This variant is listed in the Genome Aggregation Database (gnomAD) with a population frequency of 0.02 percent in the European Non-Finnish population (identified on 12 out of 56,600 chromosomes) and has been reported to the ClinVar database (Variation ID: 199776). The glutamic acid at the second codon is weakly conserved and before the signal peptide which is cleaved off before insertion into the plasma membrane. Computational analyses of the p.Glu2Lys variant on protein structure and function provide conflicting results (SIFT: damaging, PolyPhen-2: benign). Altogether, there is not enough evidence to classify the p.Glu2Lys variant with certainty. -

not provided Uncertain:1
Dec 29, 2023
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Reported in one Danish individual fulfilling task force criteria for a diagnosis of ARVC (PMID: 20864495); Identified in 15 individuals from a cohort of 30,716 predominantly European individuals undergoing exome sequencing and review of available electronic health records indicated that none of these individuals had a documented diagnosis of ARVC (PMID: 28471438), although specific clinical details and follow-up cardiac evaluations were not reported; In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23911551, 26264440, 20864495, 31402444, 28471438) -

Familial isolated arrhythmogenic right ventricular dysplasia Uncertain:1
Jan 11, 2024
All of Us Research Program, National Institutes of Health
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This missense variant replaces glutamic acid with lysine at codon 2 of the DSC2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 26264440). This variant has been identified in 16/149434 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -

Cardiomyopathy Benign:1
Mar 26, 2024
Color Diagnostics, LLC DBA Color Health
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Oct 04, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Benign
-0.18
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.047
T;.
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.062
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.36
T;T
M_CAP
Benign
0.061
D
MetaRNN
Benign
0.098
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.34
N;N
PhyloP100
3.9
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-0.11
N;N
REVEL
Benign
0.26
Sift
Uncertain
0.0090
D;D
Sift4G
Uncertain
0.060
T;T
Polyphen
0.0
B;B
Vest4
0.67
MutPred
0.29
Gain of MoRF binding (P = 0.0071);Gain of MoRF binding (P = 0.0071);
MVP
0.65
MPC
0.082
ClinPred
0.12
T
GERP RS
3.7
PromoterAI
-0.048
Neutral
Varity_R
0.16
gMVP
0.76
Mutation Taster
=11/89
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs762556795; hg19: chr18-28681931; API